Originally from the finance and wealth management world, Physique 57 Founder Jennifer Maanavi states, "I always wanted to get into the business world, and I was always a dancer growing up . . . I never thought I could combine both!" After purchasing the well known Lottie Berk Method studio on the Upper East Side, Jennifer brought things to another level. She discusses their (very careful) expansion, the early days of the brand, the difficult question of "whose client it is" (teacher or the brand?), their intensive 200 hour training program, (the average length of service for an instructor is 4 years!), the pro's and con's of external capital, maintaining quality control as you franchise, discussions of the losses of being an entrepreneur, and more!
Jennifer Maanavi, Founder & CEO, Physique 57
Get every new HALO Talks episode!
Each week, host Pete Moore sits down with the founders, operators, finance execs, and investors shaping the Health, Active Lifestyle, and Outdoor sector. Get new episodes in your inbox, no hype or BS, just the people building the sector.
Email has been submitted.
Recent Episodes
- Episode #618: Med Spa Expansion, Regulation, and Niches-Insights from Amanda Guarniere of GuardianMD
- Episode #617: From the Marines to Boardrooms-Jon Sheldon's Lessons on Leadership and Team Dynamics
- HALO Talks Fast Break: Revolutionizing Club Benefits-Amy Bach on Welld Health's Impact Across 10,000 Locations
- Episode #616: Regenerative Medicine, Market Education, and the Future of Wellness-Insights from Bill Quateman
- Episode #615: Inside Austin Pickle Ranch with Tim Klitch-Growth, Community, and Private Equity in Pickleball
- Episode #614: Building Sweathouz (SWTHZ)-Nico Varano on Scaling, Unit Economics, and Operational Excellence
- Episode #613: SoulFire's Formula-Blending Brand Identity, Community, and Profitability in Boutique Fitness
- Episode #612: Building Community Through Contrast Therapy-Carrie Bacon's Vision for 180 Degree Bathhouse
- Episode #611: Outpatient Innovation-Dr. Munir Ghesani Discusses Theranostics, Expansion, and Clinical Trials
- See all →